Executive Committee

The Executive Committee both manages and represents ERS by directing and conducting the general activities of the Society on behalf of the General Assembly. The Executive Committee provides an annual report on all activities to the General Assembly.

Committee members

Carlos Robalo Cordeiro - profile image
Carlos Robalo Cordeiro
President

Declaration of Interests

Declaration of Interests of

Annual Declaration of Interest 2021-2022

1 - Personal interests

Regular Paid Consultancy Work

None

Personal Benefits
CompanyPurpose of PaymentAmount of funds received*
Boehringer IngelheimAdvisory/LecturesB
RocheAdvisory/LecturesB
Astra ZenecaAdvisory/LecturesB
NovartisAdvisory/LecturesB
GSKAdvisory/LecturesB
PfizerAdvisory/LecturesB
TevaAdvisory/LecturesB
MSDAdvisory/LecturesB
SanofiAdvisory/LecturesB
Personal Travel Grants or expenses for conferences etc.

None

Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

CompanyNature of SupportAmount of funds received*
Boehringer IngelheimEducational GrantsC
RocheEducational GrantsC
NovartisEducational GrantsC
Astra ZenecaEducational GrantsC
GSKEducational GrantsC
BMSEducational GrantsC
MSDEducational GrantsC

3 - Other Interests that may be seen as potential conflicts

None

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
ABCD
less than € 1'000€ 1001 - € 5'000€ 5'001 - € 20'000more than € 20'000
Marc Humbert - profile image
Marc Humbert
Past President

Declaration of Interests

Declaration of Interests of

Annual Declaration of Interest 2021-2022

1 - Personal interests

Regular Paid Consultancy Work
CompanyAreaProductAmount of funds received*
Johnson and Johnson (Janssen)Pulmonary hypertensionBosentan, macitentan, epoprostenol, selexipagC
MSDPulmonary hypertensionRiociguatC
GSKAsthma, COPDMepolizumabB
FerrerPulmonary hypertensionTreprostinilB
AcceleronPulmonary hypertensionSotaterceptC
BayerPulmonary hypertensionRiociguatB
AOP OrphanPulmonary hypertensionTreprostinilB
AltavantPulmonary hypertensionRodatristatB
Shou TiPulmonary hypertensionPipelineB
MorphogenIXPulmonary hypertensionPipelineB
ChiesiPulmonary hypertension, COPDPipelineB
Astra ZenecaAsthmaBenralizumabC
NovartisAsthmaOmalizumabB
SanofiAsthmaDupilumabB
Personal Benefits

None

Personal Travel Grants or expenses for conferences etc.

None

Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

CompanyNature of SupportAmount of funds received*
Johnson and Johnson (Janssen)Pulmonary hypertension translation researchD
MSDPulmonary hypertension translation researchD
AcceleronPulmonary hypertension translation researchD
Shou TiPulmonary hypertension translation researchD

3 - Other Interests that may be seen as potential conflicts

None

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
ABCD
less than € 1'000€ 1001 - € 5'000€ 5'001 - € 20'000more than € 20'000
Monika Gappa - profile image
Monika Gappa
President Elect

Silke Ryan - profile image
Silke Ryan
Vice President

Judith Garcia-Aymerich - profile image
Judith Garcia-Aymerich
Secretary General

Peter Wijkstra - profile image
Peter Wijkstra
Treasurer

Richard Costello - profile image
Richard Costello
Education Council Chair

Declaration of Interests

Declaration of Interests of

Annual Declaration of Interest 2021-2022

1 - Personal interests

Regular Paid Consultancy Work

None

Personal Benefits

None

Personal Travel Grants or expenses for conferences etc.

None

Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

None

3 - Other Interests that may be seen as potential conflicts

None

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
ABCD
less than € 1'000€ 1001 - € 5'000€ 5'001 - € 20'000more than € 20'000
Nicolas Roche - profile image
Nicolas Roche
Science Council Chair

Arzu Yorgancioğlu - profile image
Arzu Yorgancioğlu
Advocacy Council Chair

Declaration of Interests

Declaration of Interests of

Annual Declaration of Interest 2021-2022

1 - Personal interests

Regular Paid Consultancy Work

None

Personal Benefits
CompanyPurpose of PaymentAmount of funds received*
Astra ZenecaAdvisory BoardA
GSKLectureA
ChiesiAdvisory Board&LectureB
SandozLectureB
DEVAAdvisory Board &LectureA
Vem İlaç LectureA
NovartisAdvisory Board &LecturerA
Abdi İbrahimAdvisory Board &LecturesA
Personal Travel Grants or expenses for conferences etc.

None

Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

CompanyNature of SupportAmount of funds received*
MSDInstitutional GrantB
Astra zeneca Institutionai GrantA

3 - Other Interests that may be seen as potential conflicts

Company or organisationNature/Purpose of Support
GARD/WHOChair
GINA Board of Directors

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
ABCD
less than € 1'000€ 1001 - € 5'000€ 5'001 - € 20'000more than € 20'000
Kjeld Hansen - profile image
Kjeld Hansen
European Lung Foundation Chair

Declaration of Interests

Declaration of Interests of

Annual Declaration of Interest 2021-2022

1 - Personal interests

Regular Paid Consultancy Work

None

Personal Benefits

None

Personal Travel Grants or expenses for conferences etc.

None

Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

None

3 - Other Interests that may be seen as potential conflicts

None

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
ABCD
less than € 1'000€ 1001 - € 5'000€ 5'001 - € 20'000more than € 20'000
Anh Tuan Dinh-Xuan - profile image
Anh Tuan Dinh-Xuan
Publication Committee Chair

Declaration of Interests

Declaration of Interests of

Annual Declaration of Interest 2021-2022

1 - Personal interests

Regular Paid Consultancy Work

None

Personal Benefits
CompanyPurpose of PaymentAmount of funds received*
ChiesiLectures A
GSKLecturesA
NovartisLecturesA
SanofiLecturesA
Personal Travel Grants or expenses for conferences etc.

None

Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

CompanyNature of SupportAmount of funds received*
Fondation Air LiquideResearch grant on post-COVID lung function follow-upD

3 - Other Interests that may be seen as potential conflicts

None

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
ABCD
less than € 1'000€ 1001 - € 5'000€ 5'001 - € 20'000more than € 20'000
Sara Cuevas Ocaña - profile image
Sara Cuevas Ocaña
Early Career Members Committee Chair

Thomas Gille - profile image
Thomas Gille
Early Career Members Committee Co-Chair

Barbara Hoffmann - profile image
Barbara Hoffmann
Advocacy Council Chair Elect

Hilary Pinnock - profile image
Hilary Pinnock
Education Council Chair Elect

Sara Tomassetti - profile image
Sara Tomassetti
Publications Council Chair Elect

All ERS Assembly Heads are also members of the Executive Committee.